Skip to content

Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors

Post-Covid Condition Monitoring Cohort: Evaluation of the Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05610436
Acronym
SYNPOCov
Enrollment
500
Registered
2022-11-09
Start date
2022-01-07
Completion date
2026-06-30
Last updated
2022-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long COVID, Post-Acute COVID-19, Post-Acute COVID19 Syndrome

Brief summary

The aim of our cohort is to collect prospectively, in a standardized and exhaustive manner, the health data of patients referred to the CAPCoV, our holistic referal post covid clinics for post-covid condition in order to be able to identify typical profiles of patients suffering from post covid syndrome and to follow the evolution of their disease over time.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* outpatients treated in the Nancy University Hospital Long Covid Support and Care Center for post-Covid condition according to WHO definition

Exclusion criteria

* patient opposing the processing for research purposes of their data collected in routine care for their care

Design outcomes

Primary

MeasureTime frameDescription
Symptomsevery 6 months up to 3 yearsSymptoms collected in a standardized manner during consultations, their persistence over time, their evolution (improvement, stagnation, worsening) and their severity (mild, moderate, severe)

Secondary

MeasureTime frameDescription
fatigueevery 6 months up to 3 yearsChalder scale: range 0 to 33, \>22/33 classified severe
Dyspneaevery 6 months up to 3 yearsmMRC
Medical historybaseline
inappropriate hyperventilation syndromeevery 6 months up to 3 yearsNijmegen score: range 0 to 64, \>23/34 classified possible inapropriate hyperventilation syndrome
additional examinationsevery 6 months up to 3 yearsBiology, imaging
Cognitive impairementevery 6 months up to 3 yearsMontréal Cognitive Assessment : range 0 to 30, \<26/30 classified pathologic

Countries

France

Contacts

Primary ContactFrancois GOEHRINGER, MD
francois.goehringer@chru-nancy.fr+33383154097

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026